Brief: Allergy Therapeutics Commences Phase III Paediatric Trial
21/10/2024 07:29
Oct 21 (Reuters) - Allergy Therapeutics PLC AGY.L :
* COMMENCEMENT OF PHASE III PAEDIATRIC TRIAL
* PATIENT SCREENING UNDERWAY, DATA EXPECTED Q4 2025
Source text for Eikon: ID:nRSU8311Ia
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update